Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to excess the gastrin-releasing peptide receptor by an adenoviral vector

Cancer

Volumn 80, Issue 12 SUPPL., 1997, Pages 2419-2424

  Rogers, Buck E ^a   Curiel, David T ^a,b   Mayo, Matthew S ^b   Laffoon, Kim K ^a   Bright, Sheila J ^a   Buchsbaum, Donald J ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c The University of Alabama at Birmingham   (United States)

Author keywords

Adenovirus; Bombesin; Gastrin releasing peptide receptor; Gene transfer

Indexed keywords

BOMBESIN DERIVATIVE; CELL RECEPTOR; GASTRIN RELEASING PEPTIDE; IODINE 125; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; CANCER LOCALIZATION; CANCER TRANSPLANTATION; CONFERENCE PAPER; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR AFFINITY; RECEPTOR DENSITY; XENOTRANSPLANTATION;

EID: 0031471666     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2419::aid-cncr13>3.0.co;2-f     Document Type: Conference Paper

References (24)

1. Philben VJ, Jakowatz JG, Beatty BG, Vlahos WG, Paxton RJ, Williams LE, et al. The effect of tumor CEA content and tumor size on tissue uptake of Indium 111-labeled anti-CEA monoclonal antibody. Cancer 1986;57:571-6.
2. Shockley TR, Lin K, Sung C, Nagy JA, Tompkins RG, Dedrick RL, et al. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Cancer Res 1992;52:357-66.
3. Hand PH, Robbins PF, Salgaller ML, Poole DJ, Schlom J. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies. Cancer Immunol Immunother 1993;36:65-75.
4. Raben D, Buchsbaum DJ, Khazaeli MB, Rosenfeld ME, Gillespie GY, Grizzle WE, et al. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. Gene Ther 1996;3:567-80.
5. Buchsbaum DJ, Raben D, Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, et al. Approaches to enhance cancer radiotherapy employing gene transfer methods. Gene Ther 1996;3:1042-68.
6. 2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector mediated gene transfer. J Nucl Med 1997;38:1221-9.
7. Raben D, Buchsbaum DJ, Khazaeli MB, Rosenfeld ME, Gillespie GY, Curiel DT. Strategies to augment radioimmunotherapy via genetic induction of receptors for radioligand binding. Cancer Gene Ther 1995;2:330.
8. Rosenfeld ME, Rogers BE, Khazaeli MB, Mikheeva G, Raben D, Liu T, et al. Adenoviral mediated delivery of gastrin releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo. Clin Cancer Res 1997;3:1187-94.
9. Volkert WA, Goeckeler WF, Ehrhardt GJ, Ketring AR. Therapeutic radionuclides: production and decay property considerations. J Nucl Med 1991;32:174-85.
10. Yorke ED, Beaumier PL, Wessels BW, Fritzberg AR, Morgan AC Jr. Optimal antibody-radionuclide combinations for clinical radioimmunotherapy: a predictive model based on mouse pharmacokinetics. Nucl Med Biol 1991;18:827-35.
11. Gibbons JD. Nonparametric Statistical Inference. New York, NY: McGraw-Hill, 1971.
12. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Models. Chicago, IL: Irwin, 1996.
13. Rowlinson G, Snook D, Busza A, Epenetos AA. Antibody-guided localization of intraperitoneal tumors following intraperitoneal or intravenous antibody administration. Cancer Res 1987;47:6528-31.
14. Ward BG, Mather SJ, Hawkins LR, Crowther ME, Shepherd JH, Granowska M, et al. Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration. Cancer Res 1987;47:4719-23.
15. Buist M, Kenemans P. Imaging and radioimmunotargeting of ovarian cancer. Tumor Targeting 1995;1:149-62.
16. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res 1993;53:891-8.
17. Deshane J, Siegel GP, Alvarez RD, Wang M, Feng M, Cabrera G, et al. Targeted tumor killing via an intracellular antibody against erbB-2. J Clin Invest 1995;96:2980-9.
18. Rosenfeld ME, Wang M, Siegal GP, Alvarez RD, Mikheeva G, Krasnykh V, et al. Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J Mol Med 1996;74:455-62.
19. Brody SL, Jaffe A, Han SK, Wersto RP, Crystal RG. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Human Gene Ther 1994;5:437-47.
20. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ, et al. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg 1994;57:1395-401.
21. Garver RI Jr., Goldsmith KT, Rodu B, Hu P-C, Sorscher EJ, Curiel DT. Strategy for achieving selective killing of carcinomas. Gene Ther 1994;1:46-50.
22. Tanaka T, Kanai F, Okabe S, Yoshida Y, Wakimoto H, Hamada H, et al. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res 1996;56:1341-5.
23. Smith MJ, Rousculp MD, Goldsmith KT, Curiel DT, Garver RI Jr. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Human Gene Ther 1994;5:29-35.
24. Goldsmith KT, Curiel DT, Engler JA, Garver RI Jr. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells. Human Gene Ther 1994;5:1341-8.